These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 35249229)

  • 21. Long-term lamivudine monotherapy prevents development of hepatitis B virus infection in hepatitis B surface-antigen negative liver transplant recipients from hepatitis B core-antibody-positive donors.
    Prakoso E; Strasser SI; Koorey DJ; Verran D; McCaughan GW
    Clin Transplant; 2006; 20(3):369-73. PubMed ID: 16824156
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hepatitis B-core antibody positive donors in liver transplantation and their impact on graft survival: evidence from the Liver Match cohort study.
    Angelico M; Nardi A; Marianelli T; Caccamo L; Romagnoli R; Tisone G; Pinna AD; Avolio AW; Fagiuoli S; Burra P; Strazzabosco M; Costa AN;
    J Hepatol; 2013 Apr; 58(4):715-23. PubMed ID: 23201239
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Liver grafts from anti-hepatitis B core positive donors: a systematic review.
    Cholongitas E; Papatheodoridis GV; Burroughs AK
    J Hepatol; 2010 Feb; 52(2):272-9. PubMed ID: 20034693
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Anti-HBc-positive/HBsAg-negative liver donors pose a higher risk of occult HBV infection but do not cause severe histological damage in liver grafts.
    Niu Y; Chen X; Feng L; You H; Ren X; Liu H; Zheng J; Shen Z; Jia J
    Clin Res Hepatol Gastroenterol; 2014 Sep; 38(4):475-80. PubMed ID: 24835492
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Feasibility of using marginal liver grafts in living donor liver transplantation.
    Lan X; Zhang H; Li HY; Chen KF; Liu F; Wei YG; Li B
    World J Gastroenterol; 2018 Jun; 24(23):2441-2456. PubMed ID: 29930466
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pre-transplant donor HBV DNA+ and male recipient are independent risk factors for treatment failure in HBsAg+ donors to HBsAg- kidney transplant recipients.
    Wang XD; Feng SJ; Liu JP; Song TR; Huang ZL; Fan Y; Shi YY; Chen LY; Lv YH; Xu ZL; Li XH; Wang L; Lin T
    BMC Infect Dis; 2021 Jan; 21(1):41. PubMed ID: 33422017
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Liver transplantation from hepatitis B surface antigen positive donors: a safe way to expand the donor pool.
    Loggi E; Micco L; Ercolani G; Cucchetti A; Bihl FK; Grazi GL; Gitto S; Bontadini A; Bernardi M; Grossi P; Costa AN; Pinna AD; Brander C; Andreone P
    J Hepatol; 2012 Mar; 56(3):579-85. PubMed ID: 22027583
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of hepatitis B surface antigen (HBsAg) positivity of donors in HBsAg(+) renal transplant recipients: comparison of outcomes with HBsAg(+) and HBsAg(-) donors.
    Yilmaz VT; Aliosmanoglu I; Erbis H; Ulger BV; Cetinkaya R; Suleymanlar G; Kocak H
    Transpl Infect Dis; 2016 Feb; 18(1):55-62. PubMed ID: 26565663
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effect of HBsAg-positivity of kidney donors on long-term patient and graft outcome.
    Berber I; Aydin C; Yigit B; Turkmen F; Titiz IM; Altaca G
    Transplant Proc; 2005 Dec; 37(10):4173-5. PubMed ID: 16387070
    [TBL] [Abstract][Full Text] [Related]  

  • 30. De novo hepatitis B after liver transplantation from hepatitis B core antibody-positive donors in an area with high prevalence of anti-HBc positivity in the donor population.
    Prieto M; Gómez MD; Berenguer M; Córdoba J; Rayón JM; Pastor M; García-Herola A; Nicolás D; Carrasco D; Orbis JF; Mir J; Berenguer J
    Liver Transpl; 2001 Jan; 7(1):51-8. PubMed ID: 11150423
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Influence of sex on outcomes of liver transplantation for hepatocellular carcinoma: a multicenter cohort study in China.
    Chen J; Yang Z; Gao F; Zhou Z; Chen J; Lu D; Wang K; Sui M; Wang Z; Guo W; Lyu G; Qi H; Cai J; Yang J; Zheng S; Xu X
    Cancer Biol Med; 2024 Feb; 21(4):347-62. PubMed ID: 38425217
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Viral activity and outcome of hepatitis B surface antigen-positive grafts in deceased liver transplantation.
    Lee WC; Chou HS; Lee CS; Wu TH; Wang YC; Cheng CH; Lee CF; Wu TJ; Chan KM
    J Viral Hepat; 2018 Jul; 25(7):874-877. PubMed ID: 29431877
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Liver Transplantation from Brain-Dead Donors with Hepatitis B or C in South Korea: A 2014-2020 Korean Organ Transplantation Registry Data Analysis.
    Park H; Lee H; Baik S; Kim MS; Yang J; Jeong JC; Koo TY; Kim DG; Lee JM
    Ann Transplant; 2024 May; 29():e943588. PubMed ID: 38769724
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Allografts positive for hepatitis B surface antigen in liver transplant for disease related to hepatitis B virus.
    Ju W; Chen M; Guo Z; Wang D; Zhu X; Huang J; He X
    Exp Clin Transplant; 2013 Jun; 11(3):245-9. PubMed ID: 23176583
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Utilization of elderly donors in liver transplantation for patients with hepatocellular carcinoma: A national retrospective cohort study of China.
    Hu L; Zhao Z; Mu F; Dong S; Zhang C; Shi J; Tian M; Guo K; Zhang X; Yu L; Lv Y; Wang B
    Int J Surg; 2022 Sep; 105():106839. PubMed ID: 35987333
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Liver transplantation for hepatitis B virus: Decreasing indication and changing trends.
    Al-Hamoudi W; Elsiesy H; Bendahmash A; Al-Masri N; Ali S; Allam N; Al Sofayan M; Al Bahili H; Al Sebayel M; Broering D; Saab S; Abaalkhail F
    World J Gastroenterol; 2015 Jul; 21(26):8140-7. PubMed ID: 26185387
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hepatitis B virus infection in heart transplant recipients in a hepatitis B endemic area.
    Ko WJ; Chou NK; Hsu RB; Chen YS; Wang SS; Chu SH; Lai MY
    J Heart Lung Transplant; 2001 Aug; 20(8):865-75. PubMed ID: 11502409
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long term follow-up and outcome of liver transplantation from hepatitis B surface antigen positive donors.
    Ballarin R; Cucchetti A; Russo FP; Magistri P; Cescon M; Cillo U; Burra P; Pinna AD; Di Benedetto F
    World J Gastroenterol; 2017 Mar; 23(12):2095-2105. PubMed ID: 28405138
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Kidney Transplantation From Hepatitis B Surface Antigen (HBsAg)-Positive Living Donors to HBsAg-Negative Recipients: Clinical Outcomes at a High-Volume Center in China.
    Wang XD; Liu JP; Song TR; Huang ZL; Fan Y; Shi YY; Chen LY; Lv YH; Xu ZL; Li XH; Wang L; Lin T
    Clin Infect Dis; 2021 Mar; 72(6):1016-1023. PubMed ID: 32100025
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High-dose hepatitis B immunoglobulin therapy in hepatocellular carcinoma with hepatitis B virus-DNA/hepatitis B e antigen-positive patients after living donor liver transplantation.
    Lee EC; Kim SH; Lee SD; Park H; Lee SA; Park SJ
    World J Gastroenterol; 2016 Apr; 22(14):3803-12. PubMed ID: 27076765
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.